BCR (CR Bard) acquires ROCM for $20/sh in cash: http://finance.yahoo.com/news/rochester-medical-acquired-c-r-110000282.html The nominal deal price is $262M, and the premium relative to yesterdays’ closing price of ROCM is 45%. A vote of ROCM shareholders is required.